CD40LG and COVID-19: All CLIA-positive samples were collected from healthy participants who had two doses of inactivated COVID-19 vaccine (Supplementary Data 1) and their IgG and IgM levels against RBD were measured by UCAD without selection (Fig. 3b, c).